公司資料

Agilon Health 股價、新聞與催化劑

股票代碼:
AGL
交易所:
NYSE
產業:
Biopharma
所在地:
United States

股票表現

82.28 USD (+3.38%)

收盤價

最後更新: 2026年10月1日

1.45B USD

市值

股價為何變動

截至 2026年10月1日,AGL 上漲 3.38%,收於 $82.28。目前新聞監測窗口內未發現新的同公司新聞。

公司概覽

Physician Partnership Platform

agilon health partners with independent primary-care groups and health systems to operate value-based care models for senior patients. Its platform supplies technology, capital, operational processes, payer relationships, and clinical support while allowing physician partners to retain their local identity.

Total Care Model

The Total Care Model shifts participating physicians from fee-for-service reimbursement toward responsibility for the overall cost and quality of patient care. agilon and its partners share in the economics of managing Medicare populations under risk-based arrangements.

Medicare Advantage Operations

The company's consolidated business primarily supports Medicare Advantage members through contracts with health plans. Revenue is linked to member enrollment and risk-adjusted premiums, while profitability depends on accurate coding, care management, and control of medical-service costs.

ACO Model Participation

agilon also participates in CMS accountable-care models through partnered entities that are generally not consolidated into its financial statements. These arrangements extend the platform to traditional Medicare beneficiaries and provide another route for physicians to adopt value-based care.

Scaled Primary-Care Network

The platform connects approximately 2,300 primary-care physicians across roughly 30 communities. The network provides peer learning, shared operating infrastructure, and population-health capabilities that would be difficult for many independent groups to build alone.

未來催化劑

    近期新聞

    新聞標題由機器翻譯,詳情為英文原文。

      相似股票

      商業成熟度、治療領域或催化劑模式相近的同業公司。